Liran Levy

3.0k total citations · 1 hit paper
69 papers, 2.2k citations indexed

About

Liran Levy is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Liran Levy has authored 69 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Surgery, 29 papers in Pulmonary and Respiratory Medicine and 19 papers in Epidemiology. Recurrent topics in Liran Levy's work include Transplantation: Methods and Outcomes (35 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers) and Renal Transplantation Outcomes and Treatments (10 papers). Liran Levy is often cited by papers focused on Transplantation: Methods and Outcomes (35 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers) and Renal Transplantation Outcomes and Treatments (10 papers). Liran Levy collaborates with scholars based in Canada, Israel and United States. Liran Levy's co-authors include Inbal Mishalian, Janna Michaeli, Zvi G. Fridlender, Zvi Granot, Lida Zolotarov, Avi‐Hai Hovav, Sunil Singhal, John P. Fleming, Steven Μ. Albelda and Zvi G. Fridlender and has published in prestigious journals such as The FASEB Journal, Science Advances and British Journal of Cancer.

In The Last Decade

Liran Levy

64 papers receiving 2.2k citations

Hit Papers

Phenotypic Diversity and Plasticity in Circulating Neutro... 2015 2026 2018 2022 2015 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liran Levy Canada 19 1.4k 728 313 304 276 69 2.2k
Michal A. Rahat Israel 28 554 0.4× 274 0.4× 579 1.8× 163 0.5× 237 0.9× 66 1.8k
Peter Sedlmayr Austria 28 966 0.7× 317 0.4× 386 1.2× 158 0.5× 158 0.6× 69 2.0k
Michele Proietti Italy 21 779 0.6× 229 0.3× 473 1.5× 138 0.5× 111 0.4× 65 1.8k
Manja Idorn Denmark 18 475 0.3× 610 0.8× 339 1.1× 129 0.4× 79 0.3× 32 1.5k
Jan Plzák Czechia 22 346 0.3× 461 0.6× 444 1.4× 233 0.8× 345 1.3× 96 1.9k
Matthias Pierer Germany 24 919 0.7× 258 0.4× 600 1.9× 106 0.3× 145 0.5× 51 2.0k
Diana Gómez‐Martín Mexico 25 859 0.6× 177 0.2× 357 1.1× 102 0.3× 77 0.3× 81 1.8k
T Egeland Norway 24 574 0.4× 217 0.3× 191 0.6× 186 0.6× 247 0.9× 53 1.8k
Jessica Williams United Kingdom 28 419 0.3× 495 0.7× 479 1.5× 477 1.6× 723 2.6× 103 2.5k
Marcelo Hill France 27 1.1k 0.8× 218 0.3× 883 2.8× 88 0.3× 242 0.9× 44 2.4k

Countries citing papers authored by Liran Levy

Since Specialization
Citations

This map shows the geographic impact of Liran Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liran Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liran Levy more than expected).

Fields of papers citing papers by Liran Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liran Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liran Levy. The network helps show where Liran Levy may publish in the future.

Co-authorship network of co-authors of Liran Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Liran Levy. A scholar is included among the top collaborators of Liran Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liran Levy. Liran Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shaul, Merav E., et al.. (2025). Dynamic Neutrophil Subsets and Function in Lung Transplant Recipients: Insights from a One-Year Longitudinal Pilot Study. Journal of Clinical Medicine. 14(8). 2660–2660. 2 indexed citations
3.
Freund, Ophir, et al.. (2025). Real-World Experience of Dupilumab Treatment for Patients with COPD – A Single Center Prospective Study. International Journal of COPD. Volume 20. 2753–2760.
4.
Freund, Ophir, Amir Bar‐Shai, Cole D. Bendor, et al.. (2025). High rate of immediate and early post-traumatic venous thromboembolism in combat soldiers. Thrombosis Research. 252. 109382–109382.
5.
Huszti, Ella, Michael Peled, Tammy Hod, et al.. (2024). Referral rates and barriers to lung transplantation based on pulmonary function criteria in interstitial lung diseases: a retrospective cohort study. Therapeutic Advances in Respiratory Disease. 18. 2683801078–2683801078. 1 indexed citations
6.
Kawashima, M, Jin Ma, Ella Huszti, et al.. (2024). Association between cytomegalovirus viremia and long-term outcomes in lung transplant recipients. American Journal of Transplantation. 24(6). 1057–1069. 5 indexed citations
7.
Moshkelgosha, Sajad, Matthew T. White, Zehong Guan, et al.. (2024). The CD8+ T cell content of transbronchial biopsies from patients with a first episode of clinically stable grade A1 cellular rejection is associated with future chronic lung allograft dysfunction. The Journal of Heart and Lung Transplantation. 43(10). 1654–1664. 1 indexed citations
8.
Levy, Liran, Sajad Moshkelgosha, Ella Huszti, et al.. (2024). Bronchoalveolar lavage cytokine-based risk stratification of clinically-stable lung transplant recipients with undefined rejection: Further insights from a follow-up investigation. The Journal of Heart and Lung Transplantation. 44(4). 634–642. 2 indexed citations
11.
Huszti, Ella, Qixuan Li, C. Picard, et al.. (2023). Center variability in the prognostic value of a cumulative acute cellular rejection “A-score” for long-term lung transplant outcomes. American Journal of Transplantation. 24(1). 89–103. 3 indexed citations
12.
Huszti, Ella, Liran Levy, M Kawashima, et al.. (2022). Phenotyping CLAD after single lung transplant: Limits and prognostic assessment of the 2019 ISHLT classification system. The Journal of Heart and Lung Transplantation. 41(5). 599–607. 2 indexed citations
13.
Moshkelgosha, Sajad, Liran Levy, Prodipto Pal, et al.. (2021). IL‐6 receptor blockade for allograft dysfunction after lung transplantation in a patient with COPA syndrome. Clinical & Translational Immunology. 10(2). e1243–e1243. 7 indexed citations
14.
Farkona, Sofia, Zahraa Mohammed‐Ali, Max Kotlyar, et al.. (2021). Association between the renin–angiotensin system and chronic lung allograft dysfunction. European Respiratory Journal. 58(4). 2002975–2002975. 8 indexed citations
16.
Levy, Liran, Ella Huszti, Jussi Tikkanen, et al.. (2019). The impact of first untreated subclinical minimal acute rejection on risk for chronic lung allograft dysfunction or death after lung transplantation. American Journal of Transplantation. 20(1). 241–249. 33 indexed citations
17.
Levy, Liran, et al.. (2015). Splenectomy inhibits non-small cell lung cancer growth by modulating anti-tumor adaptive and innate immune response. OncoImmunology. 4(4). e998469–e998469. 49 indexed citations
18.
Sagiv, Jitka Yehudith, Janna Michaeli, Simaan Assi, et al.. (2015). Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer. Cell Reports. 10(4). 562–573. 622 indexed citations breakdown →
19.
Levy, Liran, et al.. (2012). Effects of CYP4F2 Polymorphism on Response to Warfarin During Induction Phase: A Prospective, Open-Label, Observational Cohort Study. Clinical Therapeutics. 34(4). 811–823. 20 indexed citations
20.
Levy, Liran, et al.. (2007). Faecal and serum levels of eosinophil cationic protein in a healthy paediatric population. Scandinavian Journal of Clinical and Laboratory Investigation. 67(7). 757–766. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026